Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-10-31

Clinical Trial Update: Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

View source ↗

Summary

This clinical trial update describes validation of FDG-PET segmentation tools for delineating tumors by correlating CT- and FDG-PET volume measurements with his…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Head and Neck Cancer | Status: UNKNOWN